Canada - français - Health Canada

pharmaceutical partners of canada inc - bromure de vécuronium - poudre pour solution - 10mg - bromure de vécuronium 10mg - neuromuscular blocking agents

Canada - français - Health Canada

hospira healthcare ulc - bromure de pancuronium - solution - 2mg - bromure de pancuronium 2mg - neuromuscular blocking agents

Canada - français - Health Canada

sandoz canada incorporated - bromure de pancuronium - solution - 2mg - bromure de pancuronium 2mg - neuromuscular blocking agents

Canada - français - Health Canada

sandoz canada incorporated - bromure de pancuronium - solution - 1mg - bromure de pancuronium 1mg - neuromuscular blocking agents

Canada - français - Health Canada

hospira healthcare ulc - bromure de pancuronium - solution - 1mg - bromure de pancuronium 1mg - neuromuscular blocking agents

Belgique - français - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - bromure de tiotropium 21,67 µg - eq. tiotropium 18 µg - poudre pour inhalation en gélule - 18 µg - bromure de tiotropium 21.67 µg - tiotropium bromide

Cameroun - français - DPML (Direction de la Pharmacie du Médicament et des Laboratoires)

missionpharma international - bromure de vÉcuronium - suspension injectable - 4 mg

Union européenne - français - EMA (European Medicines Agency)

novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - asthme - les médicaments pour les maladies respiratoires obstructives, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

Union européenne - français - EMA (European Medicines Agency)

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - maladie pulmonaire, chronique obstructive - les médicaments pour les maladies respiratoires obstructives, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Cameroun - français - DPML (Direction de la Pharmacie du Médicament et des Laboratoires)

ms pharma jordan - rocuronium bromide - 50 mg - solution injectable